Tag: post-approval changes
Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation
Understanding what manufacturing changes trigger FDA re-evaluation for generic drugs is critical for manufacturers and patients alike. From facility moves to formulation tweaks, not all changes are equal - and the rules determine whether a drug stays on the shelf or gets pulled for review.
Read MoreRecent News
